Nature’s Sunshine Products (NASDAQ:NATR) Downgraded to “Buy” Rating by Wall Street Zen

Wall Street Zen downgraded shares of Nature’s Sunshine Products (NASDAQ:NATR) from a strong-buy rating to a buy rating in a report issued on Saturday.

NATR has been the topic of several other reports. DA Davidson upgraded shares of Nature’s Sunshine Products to a “strong-buy” rating in a report on Monday, July 6th. Weiss Ratings lowered shares of Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, June 9th. Finally, Canaccord Genuity Group dropped their target price on shares of Nature’s Sunshine Products from $37.00 to $36.00 and set a “buy” rating on the stock in a research report on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, Nature’s Sunshine Products currently has an average rating of “Buy” and an average price target of $34.50.

Nature’s Sunshine Products Trading Down 19.5%

NASDAQ NATR opened at $16.38 on Friday. The business has a fifty day simple moving average of $20.62 and a 200 day simple moving average of $23.50. Nature’s Sunshine Products has a 12 month low of $12.97 and a 12 month high of $28.14. The firm has a market capitalization of $287.96 million, a P/E ratio of 16.22 and a beta of 0.88.

Nature’s Sunshine Products (NASDAQ:NATR) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.06). Nature’s Sunshine Products had a return on equity of 12.97% and a net margin of 3.68%.The firm had revenue of $116.99 million for the quarter, compared to analysts’ expectations of $123.70 million.

Insider Buying and Selling at Nature’s Sunshine Products

In other news, EVP Bryant J. Yates sold 11,968 shares of Nature’s Sunshine Products stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $19.90, for a total value of $238,163.20. Following the completion of the transaction, the executive vice president owned 77,446 shares in the company, valued at $1,541,175.40. This trade represents a 13.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Nathan G. Brower sold 12,015 shares of the business’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $21.84, for a total transaction of $262,407.60. Following the completion of the sale, the executive vice president directly owned 43,438 shares in the company, valued at approximately $948,685.92. This trade represents a 21.67% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 35,696 shares of company stock worth $742,407 over the last ninety days. Company insiders own 3.10% of the company’s stock.

Institutional Investors Weigh In On Nature’s Sunshine Products

A number of hedge funds and other institutional investors have recently bought and sold shares of NATR. State of Alaska Department of Revenue bought a new position in shares of Nature’s Sunshine Products in the fourth quarter worth $31,000. New York State Teachers Retirement System bought a new stake in shares of Nature’s Sunshine Products during the 1st quarter valued at $37,000. Clearstead Advisors LLC lifted its holdings in Nature’s Sunshine Products by 16,025.0% during the 4th quarter. Clearstead Advisors LLC now owns 1,935 shares of the company’s stock worth $42,000 after purchasing an additional 1,923 shares in the last quarter. McIlrath & Eck LLC purchased a new stake in Nature’s Sunshine Products during the 1st quarter worth about $48,000. Finally, Raymond James Financial Inc. purchased a new stake in Nature’s Sunshine Products during the 2nd quarter worth about $37,000. Institutional investors own 79.40% of the company’s stock.

Key Stories Impacting Nature’s Sunshine Products

Here are the key news stories impacting Nature’s Sunshine Products this week:

• Neutral Sentiment: Nature’s Sunshine appointed Ruth Perkins as executive vice president and chief financial officer, effective September 1, 2026. She will oversee the company’s global finance organization, including financial planning, accounting, treasury, tax, investor relations, and financial reporting. Nature’s Sunshine Appoints Ruth Perkins as Executive Vice President and Chief Financial Officer
• Neutral Sentiment: Management discussed the second-quarter performance and business outlook during its earnings call, providing additional context for the results and updated guidance. Nature’s Sunshine Products Q2 2026 Earnings Call Transcript
• Negative Sentiment: Second-quarter adjusted earnings were $0.21 per share, below the $0.27 analyst consensus, while revenue of $116.99 million trailed expectations of $123.70 million. The earnings and sales shortfalls raised concerns about near-term profitability and demand. Nature’s Sunshine Reports Second Quarter 2026 Results
• Negative Sentiment: The company lowered its full-year 2026 revenue outlook to $490 million–$500 million, below the analyst consensus of approximately $506.4 million. The reduced forecast likely reinforced investor concerns about slower growth. Nature’s Sunshine misses Q2 2026 sales expectations

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.